[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO991613D0 - Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering - Google Patents

Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering

Info

Publication number
NO991613D0
NO991613D0 NO991613A NO991613A NO991613D0 NO 991613 D0 NO991613 D0 NO 991613D0 NO 991613 A NO991613 A NO 991613A NO 991613 A NO991613 A NO 991613A NO 991613 D0 NO991613 D0 NO 991613D0
Authority
NO
Norway
Prior art keywords
oral administration
valproic acid
pharmaceutical microspheres
microspheres
pharmaceutical
Prior art date
Application number
NO991613A
Other languages
English (en)
Other versions
NO325723B1 (no
NO991613L (no
Inventor
Christian Langlois
Jean-Yves Lanne
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO991613D0 publication Critical patent/NO991613D0/no
Publication of NO991613L publication Critical patent/NO991613L/no
Publication of NO325723B1 publication Critical patent/NO325723B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19991613A 1996-10-07 1999-04-06 Farmasoytiske mikrosfaerer av valpronsyre, farmasoytiske former av slike for oral administrering og fremgangsmate for fremstilling av slike NO325723B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612201A FR2754177B1 (fr) 1996-10-07 1996-10-07 Microspheres pharmaceutiques d'acide valproique pour administration orale
PCT/FR1997/001762 WO1998015268A1 (fr) 1996-10-07 1997-10-03 Microspheres pharmaceutiques d'acide valproique pour administration orale

Publications (3)

Publication Number Publication Date
NO991613D0 true NO991613D0 (no) 1999-04-06
NO991613L NO991613L (no) 1999-04-06
NO325723B1 NO325723B1 (no) 2008-07-07

Family

ID=9496427

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991613A NO325723B1 (no) 1996-10-07 1999-04-06 Farmasoytiske mikrosfaerer av valpronsyre, farmasoytiske former av slike for oral administrering og fremgangsmate for fremstilling av slike

Country Status (40)

Country Link
US (3) US20020001598A1 (no)
EP (1) EP0956010B1 (no)
JP (1) JP3523270B2 (no)
KR (1) KR100334687B1 (no)
CN (1) CN100367945C (no)
AR (1) AR013613A1 (no)
AT (1) ATE216228T1 (no)
AU (1) AU731235B2 (no)
BR (1) BR9712268A (no)
CA (1) CA2267096C (no)
CO (1) CO4900080A1 (no)
CZ (1) CZ288876B6 (no)
DE (1) DE69712100T2 (no)
DK (1) DK0956010T3 (no)
DZ (1) DZ2316A1 (no)
EE (1) EE03744B1 (no)
EG (1) EG24070A (no)
ES (1) ES2174293T3 (no)
FR (1) FR2754177B1 (no)
HK (1) HK1021939A1 (no)
HR (1) HRP970537B1 (no)
HU (1) HU225103B1 (no)
ID (1) ID24596A (no)
IL (1) IL128745A (no)
IS (1) IS1985B (no)
ME (1) ME00664B (no)
MY (1) MY120521A (no)
NO (1) NO325723B1 (no)
NZ (1) NZ334399A (no)
PL (1) PL190105B1 (no)
PT (1) PT956010E (no)
RS (1) RS49602B (no)
RU (1) RU2177315C2 (no)
SI (1) SI0956010T1 (no)
SK (1) SK282113B6 (no)
TR (1) TR199900789T2 (no)
TW (1) TW508251B (no)
UY (1) UY24738A1 (no)
WO (1) WO1998015268A1 (no)
ZA (1) ZA978954B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200100660A (et) * 1999-06-07 2003-04-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake
CA2508855A1 (en) * 2002-12-16 2004-07-01 Frank Slade Abbott Valproic acid analogues and pharmaceutical compositions thereof
TWI428271B (zh) * 2004-06-09 2014-03-01 Smithkline Beecham Corp 生產藥物之裝置及方法
JP2008512386A (ja) * 2004-09-07 2008-04-24 オーファン メディカル,インコーポレイティド 改良型ghb組成物
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
CN101543631B (zh) * 2008-03-28 2012-01-11 沈阳兴齐制药有限公司 含蜂蜡的微球基质、含有它的药物组合物及其用途
EP2431031B1 (en) * 2009-05-12 2016-06-08 Amorepacific Corporation Composition for preventing hair loss or for stimulating hair growth
PE20160850A1 (es) * 2013-11-13 2016-09-23 Tillotts Pharma Ag Sistema multiparticulado para administrar drogas
CN104013596A (zh) * 2014-05-16 2014-09-03 安士制药(中山)有限公司 一种丙戊酸软胶囊及其制备方法
CN105456217A (zh) * 2014-08-27 2016-04-06 捷思英达医药技术(上海)有限公司 一种双丙戊酸钠缓释剂组合物及其制备方法
EP3675267A4 (en) 2017-08-24 2021-05-19 Mitsui Chemicals, Inc. WATER-FREE ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY
KR20200035095A (ko) 2017-08-24 2020-04-01 미쓰이 가가쿠 가부시키가이샤 리튬 이차 전지 및 비수 전해액
FR3087445B1 (fr) * 2018-10-19 2021-12-17 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition lipidique pour l'encapsulation d'une substance active et permettant le controle de la vitesse de liberation de ladite substance active
CN111012753A (zh) * 2020-01-07 2020-04-17 仁和堂药业有限公司 一种提高丙戊酸钠片剂稳定性的方法
CN112274499A (zh) * 2020-11-16 2021-01-29 仁和堂药业有限公司 一种提高丙戊酸钠片剂稳定性的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2293974A1 (fr) * 1973-03-02 1976-07-09 Kaltenbach Roger Procede et dispositif pour la granulation reguliere de divers produits
US5212326A (en) * 1979-08-20 1993-05-18 Abbott Laboratories Sodium hydrogen divalproate oligomer
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US5185159A (en) * 1983-07-20 1993-02-09 Sanofi Pharmaceutical composition based on valproic acid and a process for preparing it
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
TW209174B (no) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
AU2016992A (en) * 1991-05-20 1992-12-30 Marion Laboratories, Inc. Multi-layered controlled release formulation
FR2682677A1 (fr) * 1991-10-17 1993-04-23 Sanofi Elf Complexe forme de l'acide propyl-2 pentene-2 ouique (e) et de son sel de sodium, sa preparation et compositions pharmaceutiques le contenant.
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
US5690959A (en) * 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці

Also Published As

Publication number Publication date
ZA978954B (en) 1999-04-07
NO325723B1 (no) 2008-07-07
HUP9903855A3 (en) 2000-06-28
RS49602B (sr) 2007-06-04
DK0956010T3 (da) 2002-08-12
EP0956010B1 (fr) 2002-04-17
WO1998015268A1 (fr) 1998-04-16
EG24070A (en) 2008-05-11
YU17899A (sh) 2000-03-21
JP3523270B2 (ja) 2004-04-26
AR013613A1 (es) 2001-01-10
EP0956010A1 (fr) 1999-11-17
TR199900789T2 (xx) 1999-07-21
US20060263437A1 (en) 2006-11-23
KR100334687B1 (ko) 2002-04-27
HUP9903855A2 (hu) 2000-05-28
DE69712100T2 (de) 2002-11-28
SK36499A3 (en) 2000-12-11
CO4900080A1 (es) 2000-03-27
PL332249A1 (en) 1999-08-30
EE9900140A (et) 1999-12-15
IS4996A (is) 1999-03-11
CA2267096A1 (fr) 1998-04-16
CN1232391A (zh) 1999-10-20
US20020001598A1 (en) 2002-01-03
PT956010E (pt) 2002-08-30
UY24738A1 (es) 2001-05-31
SK282113B6 (sk) 2001-11-06
CN100367945C (zh) 2008-02-13
NZ334399A (en) 2000-05-26
CZ121199A3 (cs) 1999-08-11
CA2267096C (fr) 2003-09-16
BR9712268A (pt) 1999-08-31
PL190105B1 (pl) 2005-10-31
HU225103B1 (en) 2006-06-28
KR20000048828A (ko) 2000-07-25
US8535721B2 (en) 2013-09-17
FR2754177B1 (fr) 1999-08-06
HRP970537A2 (en) 1998-08-31
NO991613L (no) 1999-04-06
HK1021939A1 (en) 2000-07-21
ES2174293T3 (es) 2002-11-01
AU4560297A (en) 1998-05-05
HRP970537B1 (en) 2002-08-31
US20030157177A1 (en) 2003-08-21
IL128745A (en) 2004-05-12
DE69712100D1 (de) 2002-05-23
ATE216228T1 (de) 2002-05-15
IL128745A0 (en) 2000-01-31
ID24596A (id) 2000-07-27
IS1985B (is) 2005-02-15
EE03744B1 (et) 2002-06-17
CZ288876B6 (cs) 2001-09-12
AU731235B2 (en) 2001-03-29
RU2177315C2 (ru) 2001-12-27
MY120521A (en) 2005-11-30
FR2754177A1 (fr) 1998-04-10
TW508251B (en) 2002-11-01
DZ2316A1 (fr) 2002-12-28
ME00664B (me) 2007-06-04
SI0956010T1 (en) 2002-10-31
JP2000504038A (ja) 2000-04-04

Similar Documents

Publication Publication Date Title
NO991613D0 (no) Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
NO2007004I2 (no) Farmasoytisk akseptabelt salt av mykofenolsyre
IL116673A (en) Stable oral pharmaceutical composition containing an acid labile benzimidazole
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
EE04578B1 (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nendesolvaatide suu kaudu manustamiseks
NO953367D0 (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
DE69708130D1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
NO951933D0 (no) Farmasöytiske formuleringer av ibuprofen
PL328170A1 (en) Ester-type derivatives of transapovincaminic acid as drugs
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
KR970000226A (ko) S-이부프로펜의 경구용 제형
ZA913511B (en) New pharmaceutical use of benzocycloheptathiophene carboxylic acid derivatives
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
FR2725133B1 (fr) Composition pharmaceutique de fantofarone pour administration orale
ITMI941408A0 (it) Formulazione a rilascio modificato per la somministrazione di farmaci antiinfiammatori non steroidei
AU3416895A (en) Compositions and methods for the administration of delta-aminolevulinic acid and pharmaceutical equivalents thereof

Legal Events

Date Code Title Description
MK1K Patent expired